Navigate the Sarepta Therapeutics $SRPT and eteplirsen information pages
Formerly AVI BioPharma $AVII
Introduction
Webcasts and Events
Stock Analysis and Reporting
Eteplirsen Info
Media Reports and Patient Testimonials
Scientific and Medical Presentations
DMD and Competition
Infectious Disease Pipeline
Get first-hand perspective and education information from an inspiring family with two boys with DMD, plus learn how you can make a difference - visit www.DMDHero.com
Introduction
Webcasts and Events
Stock Analysis and Reporting
Eteplirsen Info
Media Reports and Patient Testimonials
Scientific and Medical Presentations
DMD and Competition
Infectious Disease Pipeline
Get first-hand perspective and education information from an inspiring family with two boys with DMD, plus learn how you can make a difference - visit www.DMDHero.com
Eteplirsen Clinical Trials and Info
NIH - NCATS program for AVI-4038, another DMD drug candidate in the AVII/SRPT pipeline.
Manufacturing - just how much would it cost to make enough drug for each boy (!50 grams per boy per year)
Royal Holloway (UK) receives EU grant and support from SRPT for eteplirsen clinical trial (11/30/2012)
Manufacturing - just how much would it cost to make enough drug for each boy (!50 grams per boy per year)
Royal Holloway (UK) receives EU grant and support from SRPT for eteplirsen clinical trial (11/30/2012)